$EDXC interview at NASDAQ site next week, news:
https://finance.yahoo.com/news/cbd-unlimited-...10554.html
CBD Unlimited Invited for Exclusive Interview at Nasdaq Market Site in Times Square
GlobeNewswire GlobeNewswireJanuary 29, 2020
CAVE CREEK, AZ, Jan. 29, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CBD Unlimited, Inc. (EDXC), formerly known as Endexx Corporation, a provider of innovative phytonutrient-based food and nutritional products, is pleased to announce the Company has been invited for an exclusive interview taking place at the Nasdaq MarketSite in Times Square, New York City on Wednesday, February 5th, 2020.
Mr. Todd Davis, CBD Unlimited’s Chairman and CEO, will be addressing the Company’s recent business developments and rapid growth of the CBD market. Once recorded, the interview will be released and immediately accessible to the public. This interview comes quickly after the Company’s new product suite launch and announcements of news related to additional international markets.
“We are thrilled to have the opportunity to share our recent developments and outlook for 2020 at the Nasdaq MarketSite in New York City,” commented Todd Davis, CEO and Chairman of CBD Unlimited. “2019 proved to be a tremendous year for our Company and we look forward to updating our audience on several new initiatives. Our team continues to cohesively exceed expectations while innovating new products and delivering to our customers. We look forward to sharing our updates directly from one of the top exchanges in the world right in the heart of New York City.”
About CBD Unlimited, Inc.
CBD Unlimited, Inc. develops and distributes all-natural CBD products derived from cannabis sativa plant (Hemp), containing less than 0.3% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain, and inflammation. The science behind these products involves over half a decade of research and experiments in order to protect the accuracy in dosage and delivery of absorption per each serving.
In the interest of providing conformity with federal and state mandates, the company has incorporated the “Gorilla-Tek” platform into its business practices. The Gorilla-Tek platform is the first standardized hardware agnostic and software solution that tracks high-risk, high-shrink regulated, and restricted products maintained under federal/state/local compliance. The platform provides asset protection, inventory management, compliance and an “end of sale” technology integration. Based on principles developed by the pharmacological industry, the integrated “Gorilla-Tek” platform is tremendously efficient as it provides up-to-the-minute accounting and product details. Gorilla-Tek increases productivity, while reducing costs for retailers and costs in time for customers.
Website: www.cbdunlimited.com
Safe Harbor Notice
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update any forward-looking statements.
Contact:
For further investor and media information, contact:
CBD Unlimited, Inc.
Todd Davis
Chairman & CEO
Todd@cbdunlimited.com
480-595-6900
https://finance.yahoo.com/news/cbd-unlimited-...10554.html
CBD Unlimited Invited for Exclusive Interview at Nasdaq Market Site in Times Square
GlobeNewswire GlobeNewswireJanuary 29, 2020
CAVE CREEK, AZ, Jan. 29, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CBD Unlimited, Inc. (EDXC), formerly known as Endexx Corporation, a provider of innovative phytonutrient-based food and nutritional products, is pleased to announce the Company has been invited for an exclusive interview taking place at the Nasdaq MarketSite in Times Square, New York City on Wednesday, February 5th, 2020.
Mr. Todd Davis, CBD Unlimited’s Chairman and CEO, will be addressing the Company’s recent business developments and rapid growth of the CBD market. Once recorded, the interview will be released and immediately accessible to the public. This interview comes quickly after the Company’s new product suite launch and announcements of news related to additional international markets.
“We are thrilled to have the opportunity to share our recent developments and outlook for 2020 at the Nasdaq MarketSite in New York City,” commented Todd Davis, CEO and Chairman of CBD Unlimited. “2019 proved to be a tremendous year for our Company and we look forward to updating our audience on several new initiatives. Our team continues to cohesively exceed expectations while innovating new products and delivering to our customers. We look forward to sharing our updates directly from one of the top exchanges in the world right in the heart of New York City.”
About CBD Unlimited, Inc.
CBD Unlimited, Inc. develops and distributes all-natural CBD products derived from cannabis sativa plant (Hemp), containing less than 0.3% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain, and inflammation. The science behind these products involves over half a decade of research and experiments in order to protect the accuracy in dosage and delivery of absorption per each serving.
In the interest of providing conformity with federal and state mandates, the company has incorporated the “Gorilla-Tek” platform into its business practices. The Gorilla-Tek platform is the first standardized hardware agnostic and software solution that tracks high-risk, high-shrink regulated, and restricted products maintained under federal/state/local compliance. The platform provides asset protection, inventory management, compliance and an “end of sale” technology integration. Based on principles developed by the pharmacological industry, the integrated “Gorilla-Tek” platform is tremendously efficient as it provides up-to-the-minute accounting and product details. Gorilla-Tek increases productivity, while reducing costs for retailers and costs in time for customers.
Website: www.cbdunlimited.com
Safe Harbor Notice
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update any forward-looking statements.
Contact:
For further investor and media information, contact:
CBD Unlimited, Inc.
Todd Davis
Chairman & CEO
Todd@cbdunlimited.com
480-595-6900
